{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-22-000108","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2022-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.957866+00:00","generated_at":"2026-06-23T22:35:09.725335+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Immunovant stockholders elect directors, ratify auditor, approve say-on-pay at 2022 annual meeting","bullets":["Three directors elected: Peter Salzmann, Douglas Hughes, George Migausky — all with >90M votes for.","Ernst & Young LLP ratified as independent auditor for FY ending March 31, 2023 (105.8M for, 33k against).","Non-binding advisory approval of named executive officer compensation passed with 87.5M for, 14.8M against.","Approximately 91% of shares entitled to vote were represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-22-000108","json":"https://secwatch.observer/filing/0001764013-22-000108.json","markdown":"https://secwatch.observer/filing/0001764013-22-000108.md","text":"https://secwatch.observer/filing/0001764013-22-000108.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000108/0001764013-22-000108-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000108/imvt-20220817x8xk.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T22:35:09.725335+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}